🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical research study is to compare the confirmed com...
Status
Completed
Location
Molecular Md
Start Date
2007-09
Trial ID
NCT00481247
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
The investigators hypothesize that, in newly diagnosed de novo chronic phas...
Status
Active Not Recruiting
Location
Chu Amiens Picardie
Start Date
2019-11-13
Trial ID
NCT04070443
The objectives of Part 1 of the study were: * To determine the rate of hem...
Status
Completed
Location
Dana Faber Cancer Institute
Start Date
1999-08-09
Trial ID
NCT00171249
Treatments Being Tested
To investigate if treatment with Imatinib results in a better outcome than ...
Status
Unknown
Location
Rigshospitalet
Start Date
2018-10-01
Trial ID
NCT03674099
Treatments Being Tested
The SOLIDARITY PLUS Finland Long-COVID trial aims to assess the long-term e...
Status
Unknown
Location
University of Helsinki
Start Date
2022-02-06
Trial ID
NCT05220280
Treatments Being Tested
This study is a randomized Double-Blind Placebo-Controlled Trial on the Saf...
Status
Terminated
Location
University of Maryland Medical Center
Start Date
2020-06-02
Trial ID
NCT04394416
Treatments Being Tested
The primary purpose of this study is to estimate the major cytogenetic resp...
Status
Completed
Location
Local Institution
Start Date
2005-02
Trial ID
NCT00103844
A randomized controlled pilot study on the safety \& efficacy of imatinib f...
Status
Unknown
Location
Multiple Locations
Start Date
2020-06
Trial ID
NCT04422678
Treatments Being Tested
The Imatinib Mesylate at a dose of 400 mg / day is the standard treatment f...
Status
Terminated
Location
Institut Bergonié
Start Date
2009-07
Trial ID
NCT01827930
Treatments Being Tested